CP
NARI

Castleview Partners’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Castleview Partners’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$52K Buy
+560
New +$54.3K 0.02% 408

Other funds holding NARI

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Castleview Partners's NARI Position: Q2 2021 in Review

Castleview Partners opened a new position in Inari Medical, Inc. Common Stock (NARI) in Q2 2021: 560 shares worth $52K. The stake represents 0.02% of the portfolio and ranks #408 among its holdings.

202 funds tracked by Wall St. Rank hold NARI as of Q2 2021.

  • Castleview Partners held 560 shares of Inari Medical, Inc. Common Stock worth $52K as of Q2 2021.
  • Inari Medical, Inc. Common Stock was a new Castleview Partners position in Q2 2021.
  • Inari Medical, Inc. Common Stock made up 0.02% of Castleview Partners's portfolio in Q2 2021, its #408 holding.
  • 202 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2021.

Based on Castleview Partners's 13F filing for Q2 2021, filed 17 Aug 2021.